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Follow-Up (n113 pts)
Any death/cardiac (n, %) 3/1 (2.6/0.9)
Stable Angina (n,%) 16 (14)
Unstable Angina (n,%) 0
MI (n, %) 1 (0.9)
Re-PCI (n, %) 12 (10.6)
TLR (n, %) 9 (7.9)
TVR (n, %) 3 (2.6)
Main Branch ISR (n, %) 0
Side Branch ISR (n, %) 14 (12.4)
- Left-main BL ISR (n) 6
- Non Left-main BL ISR (n) 8
Conclusions: In complex BL, Tryton implantation in conjunction with Xience Prime was
associated with high success rates. Clinical and angiographic follow-up showed low
restenosis rate for non-left-main BL and no stent thromboses.
TCT-679
Coronary bifurcation angle from 3-D predicts clinical outcomes after stenting
bifurcation lesions
Shao Liang Chen1
1Nanjing First Hospital, Nanjing Medical University, Jiangsu, China
Background: The predictive value of bifurcation angle (BA) for worse events after
stenting bifurcation lesions remains to be unknown. The present study was to investigate
the dynamic change of BA and clinical relevance for patients with coronary bifurcation
lesions treated by drug-eluting stent (DES).
Methods: BA was calculated by 3-D quantitative coronary analysis from 347 patients in
DKCRUSH-II study. Primary endpoint was the occurrence of composite major adverse
cardiac events (MACE) at 12-month, including cardiac death, myocardial infarction (MI)
and target vessel revascularization (TVR). Secondary end points were the rate of binary
restenosis and stent thrombosis at 12-month
Results: Stenting was associated with the reduction of distal BA. The cut-off value of
distal BA for predicting MACE was 6028. Distal BA in 60° group had less
reduction after stenting ((–1.9613.58)° vs. (–12.1223.58)°, P0.001); two-stent
technique was associated with significant reduction of distal BA ((–4.0514.20)°),
compared to single stent group(	1.5511.73, P0.003); the target lesion revascular-
ization (TLR), TVR and MACE rate was higher in one-stent group(16.5%, 19.0% and
21.5%), compared to two-stent group (3.8%, P0.002; 7.5%, P0.016; and 9.8%,
P0.024),respectively. Among patients in 60° group, there were no significant
differences in distal BA, stent thrombosis (ST), MI,MACE, death, TLR, TVR between
one- and two-stent groups; after stenting procedure, there was only slight change of distal
BA in left anterior descending (LAD)-left circumflex (LCX) subgroup (from
(88.5421.33)° at baseline to(82.4431.72)° post-stenting), compared to either LAD-
diagonal branch (Di), or LCX- obtuse marginal branch (OM), or RCA distal (RCAd) (all
P 0.001).
Conclusions: Two-stent technique was associated with significant reduction of distal
BA. DK crush stenting had reduced rate of MACE in patients in 60° group, compared
to one-stent technique
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Background: Different drug-eluting stents may have different clinical efficacy in
bifurcation interventions. Thus, we sought to compare the long term efficacy of sirolimus
(SES) and everolimus (EES) eluting stents in patients with bifurcation lesions.
Methods: We realized a cooperative, non-sponsored, pooled analysis on (previously ever
unreported) long term outcome data from 2 prospective randomized trials with similar
methodology (SEASIDE and CORPAL). In these trials, patients with all types of
bifurcations were randomly assigned to treatment with either a SES (n220) or EES
(n223) according to the provisional side-branch stenting technique. Primary end-point
of the study was the occurrence of major adverse cardiac events (MACE) (death of any
cause, acute myocardial infarction or repeat revascularization) during 3-year follow-up.
Landmark analysis for late (12 months) events was planned.
Results: A total of 443 patients with bifurcated lesions were randomized to a SES
(n220) or EES (n223). The two study group did not differed and, overall, 70.1% of
patients had target bifurcation located in the distal left main or left anterior descending
artery, 60.9% presented with acute coronary syndromes and 37.2% had Medina 1,1,1
lesion. Three-year follow-up was available in 439 (99.1%) of patients. At 3 years, MACE
occurred in 7.7% of patients and were non-significantly lower in patients randomized to
EES vs. SES: 6.8% vs. 8.7% (p0.16). Interestingly, total mortality rate was 4.1% in SES
group vs. 1.8% of EES group (p0.14). At landmark analysis for late events, MACE
occurring after 12-month were significantly reduced in patients randomized to EES
compared to SES: 1.4% vs. 5.4% (p0.02).
Conclusions: Provisional side branch stenting with SES or EES in bifurcation lesions is
associated with low rates of major adverse events at 3-year follow-up. Patients random-
ized to EES, as compared with SES, exhibited a numerically lower incidence of adverse
events during the 3-year follow-up and a significantly lower rate of adverse late (beyond
1 year) adverse events.
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Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions
(CBL) Treated With Drug Eluting Stents (DES)
Leonard Ngunga1, Po Kee Cheung1, Shantu Bundhoo1, Neil Brass1,
Benjamin Tyrrell1, Raymond Leung1, Micha Dorsch1, William Hui1
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Background: There is limited data on the long term outcomes of CBL treated with DES
Methods: We examined the outcomes of patients with CBL treated with 1st and 2nd
generation DES from 2002 to 2011. Clinical outcomes of TLR and mortality were
collected from Alberta Provincial database and medical records. Outcomes for 1st
generation DES (sirolimus–SES; paclitaxel–PES) and 2nd generation DES (everolimus–
EES) were compared over 2 yrs while the 1st generation DES were compared over 8 yrs.
Multivariate analysis was used to identify independent predictors of TLR
Results: 829 patients (79% males; mean 62 yrs) underwent coronary stenting for 940
CBL of which 66% had side branch (SB) disease. Stent use was 43% SES, 29% PES, 25%
EES. 32.2% of CBL with SB disease required SB stenting. At 2 yrs SES had lower TLR
rate compared to PES (3.8%vs7.9%; p0.004) and EES (3.8%vs5.5%; p0.015) but
similar survival rates SES 96.9%, PES 94.5%, EES 97.4%; p0.298. Patients with SB
disease undergoing SB stenting had higher TLR rates than those without SB stenting
(9.1vs5.1%; p0.044). SB stenting was an independent predictor of TLR (HR 17.5,
6.6–46.1); p0.00001. Over 8 yrs survival was similar between 1st generation DES;
(SESvsPES; 97.0%vs94.6%; p0.408). CABG rate was SES 2.5%, PES 2.3%, EES
0.8%, p0.32. Definite stent thrombosis occurred in 0.74% of lesions over 8 yrs
Conclusions: 1st and 2nd generation DES are effective in treatment of CBL with overall
low rates of TLR at 2 yrs. SES have better long term outcomes compared to PES and EES
in CBL. A single stent approach gives better long term outcomes compared to additional
SB stenting
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Long Term Outcomes Of Two Stent Technique For The Treatment Of
Complex Coronary Bifurcations In The Drug Eluting Stent (DES) Era – A
Comparison Of Three Contemporary Strategies
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Background: While main branch (MB) stent with provisional side branch (SB) stenting
is the preferred approach in the treatment of coronary bifurcations, not uncommonly a
2-stent strategy with SB stenting is required. We report the long-term outcomes of the
2-stent strategy for the treatment of coronary bifurcations using 3 contemporary
techniques
Methods: Data on coronary bifurcation stenting procedure details and clinical outcomes
was collected from medical records and our provincial catheter laboratory database. We
report the outcomes of 212 patients undergoing MB and SB stenting using DES where the
3 most frequently used techniques were Crush (CR - 48.1%), Culotte (CU - 22.6%) and
T-Stent (TS -22.2%)
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